Medical Developments International Limited (ASX:MVP)
Australia
· Delayed Price · Currency is AUD 0.6400
+0.0400 (6.67%)
May 28, 2025, 4:10 PM AEST
Medical Developments International Company Description
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.
The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask.
The company was founded in 1972 and is headquartered in Scoresby, Australia.
Medical Developments International Limited
| Country | Australia |
| Founded | 1972 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 68 |
| CEO | Brent MacGregor |
Contact Details
Address: 4 Caribbean Drive Scoresby, 3179 Australia | |
| Phone | 61 3 9547 1888 |
| Website | medicaldev.com |
Stock Details
| Ticker Symbol | MVP |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MVP2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Brent MacGregor | Chief Executive Officer |
| Anita James | Chief Financial Officer |
| Anastasia Tan | Head of Operations and Supply Chain |
| Dr. Scott Courtney | Chief Scientific Officer |
| Tara Eaton | General Counsel and Company Secretary |
| Anthony Wheal | Head of People and Culture |
| Wayne Pearce | Head of Production |
| Stefaan Schatteman | Head of Europe |
| Julianne Alexander | Head of Medical Affairs and Clinical Development |
| Jas Singh | Global Head of Respiratory |